Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000277581 refers to a long non-coding RNA gene classified as "novel transcript, sense intronic to DHX35" located within the intronic regions of the protein-coding gene DHX35[2]. There is no published data on its molecular function, involvement in biological processes, disease association, or role as a drug target. This transcript is not to be confused with the protein DHX35, an RNA helicase involved in innate immune signaling[1][3]. No aliases, molecular interactions, therapeutic relevance, or biomarker roles are currently established for this lncRNA. This entry should not be interpreted as a validated therapeutic target. For structured drug discovery work, DHX35 (the protein) is a well-characterized gene, but ENSG00000277581 is an uncharacterized transcript with no established functions or clinical relevance[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to DHX35 (ENSG00000277581).